FDA Approves Revolution Medicines Pancreatic Cancer Drug
The U.S. Food and Drug Administration has approved Revolution Medicines’ targeted cancer drug Rasonque for certain adults with metastatic pancreatic cancer, providing a new treatment option for a disease with…